EligibleTrials

E-Mindfulness Approaches for Living After Breast Cancer

Recruiting · NCT06748222 · Interventional (participants receive a specific treatment) · Lead sponsor: NRG Oncology

View the official record on ClinicalTrials.gov →
Breast CancerDepression

Interventions studied

Meditation Only Control GroupMindfulness (MAPs) Digital AppMindfulness (MAPs) Live Online

What this trial is about

NRG-CC015 is a prospective, randomized phase III clinical trial to evaluate the efficacy of two distinct digital approaches for delivering a mindfulness-based intervention: a live, instructor-led version delivered over Zoom (MAPs LO), and an app-based, self-paced version (MAPs App). Participants will include younger breast cancer survivors (BCS) who were diagnosed with breast cancer at or before age 50 years, have completed their primary cancer treatment (i.e., surgery, radiation, and/or chemotherapy) at least 6 months earlier, and report elevated depressive symptoms.

Who can take part

Age range
18 Years to 50 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 3
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

60 locations listed across 39 US states.

Showing 60 of 383 listed sites. See the official record for the complete list.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.